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Determining the function of uterine lymphocytes is challenging because of the dynamic
changes in response to sex hormones and, during pregnancy, to the invading foetal tro-
phoblast cells. Here we provide a genome-wide transcriptome atlas of mouse uterine group 1
innate lymphoid cells (ILCs) at mid-gestation. Tissue-resident Eomes+CD49a+ NK cells
(trNK), which resemble human uterine NK cells, are most abundant during early pregnancy,
and have gene signatures associated with TGF-β responses and interactions with trophoblast,
epithelial, endothelial, smooth muscle cells, leucocytes and extracellular matrix. Conventional
NK cells expand late in gestation and may engage in crosstalk with trNK cells involving IL-18
and IFN-γ. Eomes−CD49a+ ILC1s dominate before puberty, and specifically expand in second
pregnancies when the expression of the memory cell marker CXCR6 is upregulated. These
results identify trNK cells as the cellular hub of uterine group 1 ILCs, and mark CXCR6+ ILC1s
as potential memory cells of pregnancy.
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Most innate lymphoid cells (ILCs) reside in tissues, wherethey integrate the local environment and its physiology.While group 2 and 3 ILCs are well characterised across
tissues in humans and mice1, the definition of group 1 (g1) ILCs
is the most difficult due to their heterogeneity2, as illustrated by
human and murine liver g1 ILCs3. G1 ILCs include cytotoxic,
conventional NK (cNK) cells and tissue-resident ILCs in liver,
uterus, spleen, gut, salivary glands and thymus, which share with
cNK cells expression of surface markers, transcription factor T-
bet and production of IFN-γ. Little is known, however, about the
physiological role of tissue g1 ILCs, whereas tissue ILC2s and
ILC3s contribute to barrier integrity in lung and intestinal
mucosa, promote tolerance of gut bacteria and regenerate lung
epithelium upon viral infection4. G1 ILCs participate in early
responses to infection through production of IFN-γ5,6, however
conversion of cNK cells into ILC1s under the influence of TGF-β
undermines their anti-viral and anti-tumour responses7,8. Evi-
dence also suggests g1 ILCs are involved in chronic inflammation
in lung or intestine, where environmental cues drive ILC3s to
convert into IFN-γ-producing ILC1s, which exacerbate pathol-
ogy9,10. Thus, more information is available about tissue g1 ILCs
in pathology than physiology6.
Uterine ILCs contribute to optimal pregnancy outcome in
mice11–13 and g1 ILCs are the most abundant in both human and
mouse uterus14,15. Among g1 ILCs, human uterine NK (uNK)
cells maintain the integrity of endometrial arteries16 and, during
pregnancy, mediate key developmental processes and actively
regulate placentation17 and reviewed in ref. 18. For example, they
modulate trophoblast invasion, reshape uterine vasculature and
promote foetal growth17,19–21. Genetic epidemiology studies have
shown associations of pregnancy disorders with genetic variants
of Killer-cell Immunoglobulin-like Receptors (KIRs) expressed on
NK and some T cells and their variable HLA-C ligands22,23.
Other functions have been suggested for uterine lymphocytes,
including immunological tolerance24, defence against patho-
gens25,26, and roles in pregnancy complications such as mis-
carriage, although the evidence for this is controversial (reviewed
in ref. 27). Uterine ILC3s may also contribute to tissue physiology
through production of IL-22, which maintains epithelial integ-
rity28. A population of immature NK cells phenotypically over-
laps with ILC3s, suggesting potential plasticity between uterine g1
ILCs and ILC3s29. Mouse uNK cells regulate uterine vascular
adaptions to pregnancy30 as well as foetal growth31, but uterine
g1 ILCs are heterogeneous32 and could contribute to both phy-
siology and pathology of reproduction30,33.
Functional heterogeneity of uterine g1 ILCs may reflect divi-
sion of labour, or result from the conversion of a subset into
another under certain conditions determined by the stage of
reproductive life orchestrated by sex hormones. Puberty, blas-
tocyst implantation, placentation, parturition, and lactation are
accompanied by remarkable tissue remodelling, which likely
impacts on and is influenced by tissue lymphocytes. Additionally,
ILC composition and function may be also marked by innate
memory of pregnancy, which could contribute to the well-known
better outcome of second pregnancies and their less frequent
complications34.
Determining the function of uterine cell types is challenging
because of the changing nature of the organ and the limited
access to human samples. Moreover, lack of knowledge on gene
expression profiles of mouse uterine g1 ILC subsets precludes
cell type-specific gene targeting approaches in mice. Modern
immunology relies on systems biology to decode cell hetero-
geneity and ascribe functions to discrete subsets. Here we
set out to begin to resolve the heterogeneity of g1 ILCs and
provide a whole-genome transcriptome atlas of mouse uterine
g1 ILCs.
We have previously characterised three uterine g1 ILCs14,
including Eomes+CD49a+ tissue-resident (tr)NK cells, which
resemble human uNK cells, Eomes−CD49a+ ILC1s, which may
be analogous to human uterine ILC1s;13,15 and Eomes+CD49a−
cNK cells, which are presumably circulating cells in both species.
Here we determine their whole-genome transcriptional profile.
The results show that trNK cells express genes that make them
interact with most other cell types in the pregnant uterus and
therefore, akin to human uNK cells, emerge as the central g1 ILC
subset. cNK cells in the uterus may support the function of trNK
cells by producing IFN-γ and responding to IL-18. ILC1s are
most abundant before puberty, and CXCR6+ ILC1s specifically
expand in the uterus, not in the liver, in second pregnancies,
appearing as attractive candidates for memory cells. Determining
the molecular identity and function of mouse uterine g1 ILCs
may guide further work with human cells and generate oppor-
tunities for new treatments of patients with pregnancy
complications.
Results
Dynamic distribution of uterine g1 ILCs. We have previously
defined three uterine g1 ILC subsets13,14. These subsets are all
CD45+CD3−CD19−CD11blow/- NK1.1+ NKp46+ and their
surface phenotype in comparison with that of liver subsets is
shown in Fig. 1a. Here we set out to determine their distribution
during key stages of mouse reproductive life. These were: just
before puberty (3 weeks of age), during attainment of sexual
maturity (5- and 8-week old), early in gestation (gd 5.5), at mid-
gestation (gd 9.5), after placentation (gd13.5), late in gestation
(gd17.5) and post-partum (days 1, 10 and 18). The relative
abundance of different subsets at different stages was striking
(Fig. 1b and Supplementary Fig. 1). Before the onset of puberty
and exposure to sex hormones, Eomes−CD49a+ ILC1s are the
most abundant. During sexual maturation, ILC1s decrease, while
Eomes+CD49a+ trNKs increase. Upon mating, trNK cells are the
most abundant in early pregnancy, on gd 5.5. Once the placenta
has been established, at gd 13.5, trNKs decrease, while Eomes
+CD49a− cNK cells become the most abundant. A similar
landscape with cNK cells being the most abundant is observed
both at days 1 and 18 post-partum, which mark respectively the
beginning and the end stage of breast-feeding. Fertility is lower
during lactation but not at the beginning or the end35. We
observed marked differences in the distribution of g1 ILCs in the
uterus of breastfeeding and non-breastfeeding females at 10 days
post-partum, with breastfeeding females having increased trNK
cells, similar to the distribution observed at mid-gestation (gd
9.5). These results show a dynamic g1 ILC subset distribution
during reproductive lifes that likely reflects subset-specific
functions.
Genome-wide transcriptomes of uterine g1 ILCs. Genome-wide
transcriptional profiles of the three uterine g1 ILC subsets sorted
from Eomes-GFP reporter mice at mid-gestation were analysed in
multiple comparisons with the two, well-established liver g1 ILCs
subsets. RNA was extracted from uterine and hepatic lineage
negative CD45+CD11blow/-NK1.1+NKp46+ cells sorted based on
Eomes and CD49a expression as in Fig. 1a. This two-dimensional
discrimination defines uterine and hepatic Eomes+CD49a− cNK
cells, uterine and hepatic Eomes−CD49a+ ILC1s and, unique to
the uterus, Eomes+CD49a+ trNK cells. Expression of CD49a
therefore marks resident cells in both tissues36. Unbiased prin-
cipal component analysis (PCA) showed shared transcriptional
profiles between uterine ILC1s and trNK cells but highlighted
unexpected differences between uterine and hepatic ILC1s. The
PCA also confirmed similarities between uterine and hepatic cNK
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cells (Fig. 2a). Hierarchical clustering using the differentially
expressed genes with a log2 fold change cutoff of 7.5 and p-value
<0.01 confirmed that uterine and hepatic ILC1s cluster apart
(Fig. 2b), despite phenotypic similarities (ref. 14 and Fig. 1a). The
expression of Tbx21 (T-bet), Eomes, Ifng, Itga1 (CD49a), Itga2
(CD49b), Klrb1c (NK1.1), and Ncr1 (NKp46) is consistent with
the sorting strategy, though expression of Tbx21, Ifng and Ncr1 is
low in uterine ILC1s (Fig. 2c).
Surprisingly, genes associated with myeloid cells appeared
among those defining the principal component 1 (PC1), which
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explained 61% of the variance. These included Clec7a and
Clec4a3, encoding Dectin-1 and DCIR3, respectively, Adgre1
encoding F4/80, and Mertk encoding MERTK, a member of the
Tyro-3/Axl/Mer (TAM) family of receptor tyrosine kinases
(Supplementary Fig. 2A), highly expressed in CD49a+ subsets
compared to CD49a− cNK cells in both uterus and liver, thus
defining transcriptomic differences between resident and circu-
lating cells in both tissues. Flow cytometry on uterine subsets
showed expression of F4/80 and CD86 on trNK cells, MERTK on
both trNK and ILC1s and B220 on ILC1s, with trNK expressing
intermediate B220 levels (Fig. 2d). The principal component 2
(PC2) explained 18.8% of the variance, with most genes
significantly upregulated in liver ILC1s, with almost no expres-
sion in any of the other subsets, explaining in part why hepatic
ILC1s do not cluster with uterine ILC1s (Supplementary Fig. 2B).
These results mark the uterine resident CD49a+ trNK and ILC1s
as unique subsets.
Core gene signatures of uterine g1 ILCs. To compare g1 ILC
transcriptomes between and among tissues, we ran 5 compar-
isons, the results of which are summarised in the UpSet plot,
which also selects differentially expressed genes exclusively in the
chosen comparison (Fig. 3a). The first comparison was between
all liver g1 ILCs (ILC1+ cNK) versus all uterine g1 ILCs (cNK+
trNK+ ILC1). This comparison identified 265 differentially
expressed genes (Fig. 3b). Gene Ontology (GO) analysis of this
comparison for classification by biological process showed that
the most highly enriched biological pathways in uterine cells
relate to vascular endothelial growth factor (VEGF) signalling,
including Kdr, encoding VEGF receptor 2 and Pdgfra, the alpha
receptor for the platelet-derived growth factor (PDGF), but also
oxygen/gas transport, including haemoglobin chains (Hbb-Y, Hba
−X, Hbb-BH1) (Supplementary Fig. 3A and Fig. 3b). Other sig-
nificantly enriched uterine pathways included response to
hypoxia and decreased oxygen levels (Ang, Hif3a), extracellular
matrix organisation (Flrt2, Fbln1, Mmp9, Tgfbi), as well as several
pathways relating to wound healing and the regulation of blood
vessel development. TGF-β signalling genes also distinguished
uterine cells, with upregulated Dab2, Tgfb2 and Inhba (Supple-
mentary Fig. 3A and Fig. 3b). Supplementary Data 1 includes all
differentially expressed genes and pathways highlighted by the 5
comparisons. Trim2 is one of the genes differentially upregulated
only in the uterus and Itga3 encoding CD49c in the liver (Fig. 3b).
The second comparison was between liver CD49a+ ILC1s and
uterine CD49a+ trNK and ILC1s, thus excluding cNK cells, and
informing on tissue-specific profiles of CD49a+ resident cells
(Fig. 3c). The most highly upregulated genes in uterine CD49a+
cells are Gzmd, Gzme, Gzmf, Gzmg encoding non-cytotoxic
granzymes, likely involved in tissue remodelling. Indeed, other
highly expressed genes regulate extracellular matrix organisation
(Flrt2), collagen homeostasis (Ctsb, Ctss), wound healing (Hmox1,
Pdgfa, Plau), and proliferation of epithelial cells (Mmp12, Vegfa)
(Fig. 3c and Supplementary Fig. 3B). Upregulated in uterine
CD49a+ cells are also genes involved in metabolic regulation of
steroids (mainly progesterone metabolism—Dhrs9 and Srd5a1),
ketones (Slc37a2) and amines (Paox). Encoding the orphan
monocarboxylate transporter MCT1337, Slc16a13 may be speci-
fically upregulated in uterine CD49a+ cells (Fig. 3c). Other
upregulated genes in CD49a+ uterine cells are genes regulating
migration of both myeloid cells (Ccl2, Ccl12, Spp1) and
lymphocytes (Ccl7, Ccl8, Ccl17). Osteopontin-encoding Spp1
was reported to be upregulated in uterine NK cells38 and we
find that alymphoid Rag2−/−Il2rg−/− dams express less Spp1
transcripts (Supplementary Fig. 3G). Two other growth-
promoting factors, Pleiotropin-encoding Ptn, and Osteoglycin-
encoded Ogn have also been implicated in NK-cell mediated
foetal growth39, however other cells produce these growth-
promoting factors40 and we found no significant difference in
expression between wild-type and alymphoid uterus, thus
excluding Ptn and Ogn as NK-cell and lymphocyte-specific
factors driving foetal growth (Supplementary Fig. 3G). Expressing
Arg1, Arg2, Ecm1, and Tnfsf4, uterine CD49a+ cells may regulate
type-2 immunity. Unexpected was the discovery of pathways
regulating cellular import and phagocytosis, usually associated
with antigen-presenting cells. The top enriched pathway in
CD49a+ liver cells relative to CD49a+ uterine cells was negative
regulation of antigen processing and presentation of peptide via
MHC class II (Supplementary Fig. 3B). H2-Oa and H2-Ob (also
identified previously in splenic CD127+ ILC1s2) encode H2-O, an
inhibitor of MHC class II (H2-DM)-mediated antigen-loading
process. Moreover, liver CD49a+ cells may regulate T-cell
migration, with upregulated Cxcr3 and Ccr6. Indeed, Ccr6 may
be exclusively expressed in liver ILC1s. Upregulated in liver cells
are also Cd27, Cd69 and Cxcr6, which encodes a CXCL16
receptor associated with ‘memory’ liver NK cells41 (Fig. 3c).
The third comparison between the two CD49a+ uterine subsets
versus CD49a− uterine cNK cells informs on characteristics
specific to uterine resident cells (Fig. 3d). Tissue resident cells
highly express genes involved in induction of cell death (Fasl,
Hvcn1, Tnf), response to both type I interferons and IFN-γ
(including Ccl7 and very highly, Irf7) and proteolysis, with nearly
all cathepsins significantly upregulated, alongside C3, Plau and
Cpq (Supplementary Fig. 3C). This suggests that uterine resident
cells are involved in protein processing during tissue remodelling.
Enriched pathways are chiefly unsaturated fatty acid biosynthesis
(Mgst1) and lipid metabolism (Apoe, Psap) (Fig. 3d and
Supplementary Fig. 3C). When analysed by flow cytometry,
uterine Eomes+ CD49a+ trNK cells are highly granular14, like
their human counterpart. Consistent with this, the lysosomal
transport (CD68, Rab7b, Lamp1 and Lamp2) is enriched in tissue
resident cells. The most upregulated genes in resident CD49a+
cells are Ccl7, Ccl2 and Tlr1 (Fig. 3d). RT-PCR analysis confirmed
higher expression of Ccl2, Ccl7, and Ccl12 by uterine trNK (4.9,
9.7 and 25 folds, respectively) and ILC1s (1.4, 3 and 8.3 folds,
respectively), compared to cNK cells. Tissue resident cells
Fig. 1 Dynamic distribution of uterine group 1 innate lymphoid cells (g1 ILCs) during reproductive life. a Gating strategy for analysis and sorting by flow
cytometry, with all freshly isolated g1 ILCs at mid-gestation (gd 9.5) gated on scatter and then defined as single live CD45+CD3−CD19−CD11blow/-NK1.1
+NKp46+; ILC1 cells defined as CD49a+Eomes−; tissue-resident NK (trNK) cells defined as CD49a+Eomes+ and conventional NK (cNK) cells defined as
CD49a−Eomes+. Each panel is representative of at least a hundred independent samples. b Landscape of uterine g1 ILCs during reproductive life; numbers
in plot indicate mean percentage of each individual subset of g1 ILCs as gated within live CD45+CD3−CD19−CD11blow/-NK1.1+NKp46+ parent population.
The size of the mean data points (filled circles) is proportional to the increasing percentage of the indicated subset. Inset shows the same time-point as the
dashed rectangle below but in non-breastfeeding females. Data are representative of fifteen independent experiments with three individual animals for
each time-point analysed. Mating for experiments (just after animals turn 8-weeks old) and partum (gd 19.5–21.5) time-points are indicated by the arrows
on the plot. w week, d day, gd gestation day, pp post-partum, BF breastfeeding, nBF non-breastfeeding
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specifically upregulate the transcriptional repressor Hic2, as well
as Il6, Hint2 and Clec4b1. Highly upregulated exclusively in
uterine cNK cells, as reported previously for splenic cNK cells2, is
S1pr5 encoding sphingosine-1-phosphate receptor 5, which
regulates NK-cell egress. One of the highest fold-change
upregulated genes in uterine cNK cells is Muc4 encoding Mucin4,
involved in epithelial cell integrity and homoeostasis.
The fourth comparison was between uterine trNK cell and cNK
cells. The mutually exclusive expression of CD49a (Itga1) in trNK
cells and CD49b (Itga2) in cNK cells reflected the cell-sorting
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strategy (Fig. 3e). About 900 pathways were detected in this
comparison (Supplementary Fig. 3D), including those involved in
responses to IFN-γ and IL-18. Upregulated in trNK cells are Il18
and Ifngr2, while Ifng, Il18r1 and Il18rap are upregulated in cNK
cells. This suggests that trNK cells respond to IFN-γ and produce
IL-18, while cNK cells respond to IL-18 and produce IFN-γ,
(Fig. 3e). trNK cells may also respond to and produce IL-1β,
through highly expressed Il1r1, Ccl17, Ccl8 (cellular response to
IL-1) and Il1b, Nlrp1b, Nlrp3 (IL-1β production). Among the
most highly enriched pathways in trNK cells were those related to
cholesterol storage and homoeostasis, with genes such as Apob,
Lpl and Pparg upregulated in trNK cells (Fig. 3e and
Supplementary Fig. 3D). Interestingly, apoptotic cell clearance
was among the enriched pathways, with Lrp1, Axl and Mertk
highly upregulated in trNK compared to cNK cells. Lrp1 encodes
CD91, a receptor of many ligands and functions. In addition to
roles in apoptosis, and more widely being a haemoglobin
scavenger receptor, it also binds growth factors, including TGF-
β. Therefore, uterine trNK and ILC1s may be highly responsive to
TGF-β, through receptors such as CD91, Tgfbr1 and Tgfbr2. In
addition, Tgfbi, encoding transforming growth factor-beta
induced protein (TGFBIp, BIGH3), is also upregulated in trNK
cells. UpSet pointed to Slc16a1, encoding the cell exporter of
lactate MCT1, to be uniquely upregulated in trNK cells,
emphasising the potential importance of anaerobic glycolysis
for fuelling uterine CD49a+ cells42. Biglycan, encoded by Bgn, is a
CD44 ligand that may be involved in the recruitment of
circulating CD16− NK cells into human endometrium43 and is
upregulated in trNK cells (Supplementary Fig. 3F). Regulators of
cellular extravasation such as Adam8, Ccl2 and Ptafr are
upregulated in trNK, while Itga4 and Fam65b are upregulated
in cNK, suggesting migratory behaviour in both subsets, albeit
through potentially different mechanisms (Supplementary
Fig. 3F). Ly86, Ly96, CD180, Sash1 are all significantly
upregulated in trNK and part of highly enriched
lipopolysaccharide-mediated signalling pathway. MyD88-
dependent toll-like receptor (TLR) signalling is also specific to
trNK cells, with Tlr1, Tlr2, Tlr8, and Tlr9 highly upregulated
(Supplementary Fig. 3F). Lysosome organisation pathway is
enriched in trNK, just like complement and haemostasis
regulation with C3, F7, F10 and Ptrpj. Also, C3ar1 and C5ar1,
involved in complement receptor signalling are upregulated in
trNK cells. Some of the most highly upregulated genes in trNK
cells include P2ry1 and P2rx4, suggesting that purinergic receptor
signalling pathway is highly enriched. Plau, Pdgfa, Sema6D,
Bmpr1a, Plxna1, Itgb3 are all part of smooth muscle cell
migration pathway and upregulated in trNK cells (Supplementary
Fig. 3F). Other pathways enriched in trNK cells include hormone
and sphingolipid catabolism, prostaglandin synthesis, detection of
external biotic stimulus, regulation of nitric oxide biosynthesis,
regulation of TGF-β production and tissue remodelling. Msr1,
encoding macrophage-scavenger receptor 1 and Clec7a, encoding
Dectin-1 exhibited the highest fold change in trNK compared to
cNK (about 300-500-fold, respectively). One of the genes
upregulated almost 40-fold in trNKs is Slc40a1, encoding
ferroportin (FPN1), which is the main exporter of iron from
cells, suggesting that iron metabolism may be of importance in
uterine trNK cells. Our dataset shows high expression of Nfe2l2
(NRF2) and significantly upregulated Nfe2l3 (NRF3) in trNK
cells44. Both can bind to antioxidant stress response elements and
Nfe2l3 locus has been shown to be associated with endometriosis
through genome-wide association studies45 (Supplementary
Fig. 3F).
The fifth comparison between uterine ILC1s and trNK cells
highlights transcriptome profiles specific to uterine resident cells
(Fig. 3f). The most highly upregulated gene in uterine ILC1s
compared to trNK is Aplnr, encoding for the adipokine apelin
receptor, which is highly expressed in mouse endometrium46.
Other highly expressed genes in ILC1s include Adgre4, encoding
the macrophage-specific F4/80 receptor, as well as Ace, encoding
angiotensin I-converting enzyme of the renin-angiotensin system.
The most highly enriched pathway in ILC1s is regulation of
protein heterodimerisation activity, including Hes1, which
interacts with the Notch pathway that is key for ILC develop-
ment. Among the most highly enriched pathways detected in
ILC1s is antigen processing and presentation of peptide via MHC
class II, with H2-Aa, H2-DMb1, H2-Ab1, H2-Eb1 and CD74
highly expressed, albeit they are also expressed in trNK cells.
Enriched in trNK cells and downregulated in ILC1s are Gzmc,
Gzmd, Gzme, Gzmf and Gzmg, assigning tissue-remodelling
properties to trNK cells. Most of these granzymes were previously
shown to peak in mid- to late gestation47. Interestingly, Xcl1
encoding lymphotactin is highly expressed by trNK cells (Fig. 3f).
XCL1 is also produced by human uNK cells and regulates
trophoblast invasion48. trNK cells highly express Cd96 encoding
for the nectin-binding receptor Tactile, and Crtam, encoding a
receptor for Nectin-like molecules, Sh2d1a, encoding SAP, as well
as Sh2d1b2, encoding EAT-2B, also a member of SAP-family of
adapters. In addition, several T-cell differentiation and activation
pathways are enriched in trNK cells, including CD28, Zap70, and
Itk. (Fig. 3f). The trNK signature suggests also regulation of
myeloid cell differentiation, through Ets1 and Itgb3. Other genes
highly expressed in trNK cells regulate protein localisation to
plasma membrane, such as Rab37, Sytl2, Ptch1, Kcnip3, Skap1,
Map7.
Uterine g1 ILCs express CXCR6, IL22 and some are ex-ILC3s.
Although our genome-wide transcriptome analysis showed sig-
nificant upregulation of Cxcr6 in liver ILC1s (Fig. 3c), both liver
and uterine ILC1s express higher CXCR6 protein levels than
trNK cells (Fig. 4a). Because there is some overlapping between
immature NK cells, ILC1s and ILC3s in other tissues2, we
investigated the lineage relationship among the uterine g1 ILCs
using fate mapping reporter mice in which all cells that have
expressed, or actively express the RORγt-encoding Rorc gene are
marked by YFP. Figure 4b shows presence of YFP+ cells among
uterine g1 ILCs, which are aligned with ‘ex-ILC3s’ described in
other tissues. The human equivalent cells reported previously as
stage 3 precursor NK cells29 or NKp44+ ILC3s15 produce IL-22.
We found that trNK in the mouse uterus at mid-gestation also
Fig. 2 Genome-wide transcriptomes of uterine g1 ILCs at mid-gestation. a Unbiased principal component analysis (PCA)-based clustering of uterine ILC1s,
trNK and cNK cells and of liver ILC1s and cNK cells. The 250 most variable genes and the two principal components were used for clustering and to
describe the variance between the subsets. b Heat map of all significant differentially expressed genes with a log2fold change >7.5, selected from
comparisons described in the text and presented in Fig. 3a. c Individual gene expression plots of genes encoding proteins used for sorting g1 ILCs and
additional genes used for validation of the ILC and NK-lineages. Scale represents log2(FPKM+ 1) transformed normalised reads. d Individual gene
expression plots of genes encoding F4/80, MERTK, CD86 and B220 in uterine and liver g1 ILCs and flow cytometry validation of their protein products.
Histograms show protein expression on three uterine g1 ILCs gated as gated in Fig. 1a (red line-ILC1s, blue line-trNK, orange line-cNK). FPKM fragments per
kilobase of exon model per million reads mapped
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produce IL-22, regardless of the stimulation and, to a lesser extent
so can ILC1s (Fig. 4c–e). Although Cd27 and Cd69 are both
upregulated in liver CD49a+ cells (Fig. 3c), CD27 and CD69
proteins are present at similar levels in both uterine and hepatic
cells (Fig. 4f). Both transcripts and Ly49 protein expression levels
are slightly higher in trNK cells than in ILC1s and cNK cells
within the uterus (Fig. 4f). Despite variable levels of mRNA, all
three subsets in the uterus have similar protein levels of NKG2D
(Fig. 4f). Bimodal distribution of NKG2A/C/E expression was
observed for trNK cells as well. CD62L-encoding Sell and CD62L
are both upregulated in uterine cNK, similarly to what was
reported previously for splenic cNK cells2. CD103 is expressed by
trNK cells and, to a lower level, by uterine ILC1s, but not by
hepatic ILC1s. However, transcripts levels of CD103-encoding
Itgae are very low in all five subsets, suggesting high mRNA
turnover and potential importance of CD103 in maintaining
tissue-residency of g1 ILCs (Fig. 4f). trNK cells were also more
proliferative at gd 9.5, as measured by the Ki67 stain (Fig. 4f). A
prediction model confirmed unique features of uterine g1 ILCs
(Supplementary Fig. 4)
CXCR6 marks candidate memory uterine g1 ILCs of preg-
nancy. Adaptive, or memory NK cells have been described in
humans and mice and CXCR6 is associated with memory NK and
T cells in mice49,50. It is conceivable that subsets of g1 ILCs
expand in response to pregnancy-specific cues in second preg-
nancies and possibly contribute to the lower rate of complications
in second pregnancies. We therefore compared the distribution of
group 1 ILCs between first and second gestations and found no
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significant differences in trNK or cNK cells composition (Fig. 5a,
b). In sharp contrast, both the frequency and absolute numbers of
ILC1s at mid-gestation raise 4–5 fold in second pregnancies
(Fig. 5a, b and Supplementary Fig. 5) and ILC1s in second
pregnancies upregulate CXCR6 (Fig. 5c), suggesting these cells
respond to pregnancy-specific cues and expand in second preg-
nancies. These results mark uterine CXCR6+ ILC1s as potential
memory cells of pregnancy.
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Disscussion
We show differences in subset composition at different key stages
of mouse reproductive life. ILC1s are dominant before puberty,
whereas trNKs in early gestation, peaking at gd 5.5 and cNK cells
abund in late gestation. The dynamic composition of g1 ILCs, and
the whole-genome transcriptome atlas we provide here suggests
that g1 ILCs are attuned to uterine remodelling and may have
specific functions. The picture emerging is one of trNK cells being
the hub of uterine g1 ILCs (Fig. 6), as they interact with the
important cell types and factors in the pregnant uterus, including
TGF-β, blood vessels, smooth muscle cells, glandular epithelial
cells, trophoblast, and leucocytes, including cNK cells. In a cross
talk similar to that of macrophages with peripheral NK cells,
trNK cells may make IL-18 and stimulate cNK cells in the uterus,
which in turn produce IFN-γ and stimulate trNK cells, which
unexpectedly also both respond to and produce IL-1. IL-1 and IL-
18 are part of the same family of cytokines, which also include the
alarmin IL-33, and these are emerging as important factors in
reproductive biology and pregnancy complications12,51. IFN-γ is
the key cytokine required for the reshaping of decidual vascu-
lature in mice that leads to the formation of the placenta. As
shown before using histological criteria for subset definitions,
cNK cells are the main source of IFN-γ, while other NK-cell
subsets produce angiogenic factors52. Our data confirm this
division of labour among g1 ILCs, with cNK cells supporting
trNK cells to engage with vasculature and other components of
the pregnant uterus. Because cNK cells expand after the estab-
lishment of the placenta, it is tempting to speculate that they
specialise in immune function defending the uteroplacental unit
against pathogens.
The core signatures of uterine resident trNK cells and ILC1s
are marked by genes involved in tissue homoeostasis, metabolism,
genes associated with myeloid cells, cell death, interferon signal-
ling, protein processing and fatty acid biosynthesis. The intra-
tissue comparison between uterine trNK cells and cNK cells
highlighted genes involved in cholesterol storage, apoptotic cell
clearance, aerobic glycolysis, TLR signalling, iron transport, TGF-
β signalling as well as Axl and Mertk of the Tyro-3/Axl/Mer
(TAM) family of receptor tyrosine kinases. Gas6, a ligand for
Mertk is expressed by trophoblast53. TGF-β signalling drives the
transdifferentiation of cNK cells into ILC1s, through an inter-
mediate state that is the phenocopy of uterine trNK cells7. TGF-β
may drive a similar plasticity programme in the uterus whereby
cNK and trNK cells convert into ILC1s in second pregnancies,
thus partly contributing to generation of candidate memory cells.
In our fate mapping experiments plasticity between ex-ILC3s and
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g1 ILCs was evident. Moreover, IL-22 production by mouse trNK
cells aligns them with the previously described human stage 3
uterine NK cells29, also described as NKp44+ ILC3s15.
The comparison between uterine trNK and ILC1s revealed that
trNK cells contribute to tissue remodelling through non-cytotoxic
granzymes, cell–cell interactions through nectin receptors CD96
and CRTAM, as well as the chemokine XCL-1 and the trans-
forming growth factor-beta induced protein TGFBIp, also known
as BIGH3. XCL-1 is expressed by uNK cells, and its receptors by
both uterine myeloid cells and invading trophoblast in humans48.
Therefore XCL-1 emerges as a key molecule in the interactions
between maternal lymphocytes and foetal cells, joining other
molecular interactions, which include MHC class I receptors
NKG2A, human KIR and LILRB, and murine Ly49 (reviewed in
ref. 54). BIGH3 appears as another good candidate for the
molecular interactions between resident uterine g1 ILCs and
maternal endothelial, smooth muscle cells, as well as foetal tro-
phoblast cells. With trNK and uILC1s expressing various TGF-β
receptors TGF-βr1, -βr2 and CD91, it is tempting to speculate
that TGF-β induces the secretion of BIGH3 by these cells, which
in turn regulates downstream events essential for successful
placentation, such as invasion of trophoblast, vascular remodel-
ling, and angiogenesis. Indeed, previous studies show peak
expression of uterine BIGH3 at day 4 of gestation, when tro-
phoblast invasion starts55.
A number of unexpected genes and pathways were highlighted
in trNK cells and ILC1s. Uterine ILC1s may be involved in cross
talk to adipocytes through the expression of the receptor for
apelin. They also express the angiotensin I-converting enzyme,
suggesting a potential role in regulating blood pressure, which is
of paramount importance during gestation. Genes involved in
complement, IL-1-induced plasminogen activation, as well as
haemostasis appear upregulated in trNK cells, which may be
involved in inflammation, its accompanying vascular response
and the ensuing tissue remodelling. Upregulated in trNK cells are
Fth1 and Ftl1 encoding ferritin heavy and light chains, with Fth1
20-fold upregulated in trNK compared to cNK, and also one of
the genes with the highest number of reads. It is therefore possible
that trNKs store and export iron or, alternatively, trNK cells
respond to oxidative stress induced by iron. Consistently with this
possibility, Hmox1, which prevents inflammatory tissue injury, is
upregulated in trNK cells. Along these lines, genes activated by
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Fig. 6 Suggested g1 ILC functions in the pregnant mouse uterus. Eomes−CD49a+ ILC1s are dominant before puberty and specifically expand in second
pregnancies, when the expression of CXCR6 is upregulated, marking them as potential memory cells. Eomes+CD49a+ NK cells (trNK) are most abundant
during early pregnancy and may well be the cellular hub of uterine g1 at mid-gestation. They indeed showcase gene signatures of responsiveness to TGF-β,
connections with trophoblast, epithelial, endothelial and smooth muscle cells, leucocytes, as well as extracellular matrix. They also express genes involved
in anaerobic glycolysis, lipid metabolism, iron transport and protein ubiquitination. Conventional NK cells expand late in gestation and may engage in
crosstalk with trNK cells involving IL-18 and IFN-γ
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oxidative stress and encoding enzymes that detoxify reactive
intermediates through glutathione-dependent transferase and
peroxidase activities, such asMgst1,2 are also upregulated in trNK
cells. These pathways are important in the biology of DC and
T cells56,57 and future work will establish if uterine g1 ILCs
require these pathways and whether their differentiation is
modulated by metabolism. In a recent study, Srebp proteins and
genes involved in fatty-acid and cholesterol synthesis appeared
essential for the metabolic reprogramming of NK cells in
response to cytokine stimulation58,59. Interestingly, our analysis
reveals that uterine, not liver resident g1 ILCs upregulate
Slc16a13, which encodes lactate and pyruvate cell exporter
MCT1337. Warburg-like glycolysis is indeed important for
decidual development60 and trNKs and ILC1s may provide lac-
tate for the development of undifferentiated stromal cells in
addition to other sources which function through other MCTs
(MCT4). Also, uterine resident g1 ILCs may produce lactate as a
signal for arterial remodelling, similar to the tumour micro-
environment61. The membrane receptor for the high-density
lipoprotein cholesterol Scarb1 is also upregulated in trNK cells, as
well as pathways involved in low-density lipoprotein particle
remodelling (Abcg1, Pla2g7, Mpo) and lipid storage (Apoe, Soat1,
Hexb, Plin2, Gm2a, Ehd1), suggesting that lipid metabolism may
be important for trNK cells. Interestingly, human SCARB1
polymorphism associates with the outcome of in vitro fertilisa-
tion62. Upregulated in g1 ILCs is also Dectin-1, an important
glucan receptor for anti-fungal immunity on macrophages.
Recently, peripheral NK cells were shown to recognise beta 1,3
glucan through NKp3063, suggesting macrophage-like recogni-
tion patterns in NK cells too. Consistently with this notion, we
detected a number of upregulated genes involved in pathways of
microbial molecular pattern recognition. Genes associated with
B-cells, or for protein turnover, antigen processing and pre-
sentation, as well as the macrophage-associated F4/80 marker are
upregulated in ILC1s. The role of these B-cell and myeloid
markers on uterine ILC1s is unknown, and a recently described
subset of NKB cells is controversial64,65, but might be induced in
SIV and HIV infection66. The deconvolution model we have
applied here confirms that uterine g1 ILCs have expression pro-
files aligned with those of cell types other than NK cells and
including myeloid cells. A clear limitation of the model is that
there are no available ILCs defined in the dataset. Therefore, our
results provide new data specific to uterine g1 ILCs at mid-
gestation as a new resource for building predictive phenotype
models.
Both liver and uterine ILC1s express higher levels of ‘memory’
marker CXCR6, which prompted us to look for potential changes
in the subset composition in first and second pregnancies, with
the idea that CXCR6+ ILC1s may be more abundant in second
pregnancies. This was indeed the case and we suggest these cells
may be associated with memory of pregnancy in the mouse and
expand specifically in response to local cues. One possibility is
that the CXCR6 ligand CXCL16, expressed also by trophoblast
cells, drives ILC1 expansion during pregnancy. Interestingly,
pregnancy-trained decidual NK cells have recently been described
in humans67, which may contribute to the lower rate of com-
plications that accompany second pregnancies34.
In conclusion, we provide a transcriptome atlas of uterine g1
ILCs. Many genes in the UpSet lists are annotated genes that do
not have a canonical name yet and include pseudogenes, long
non-coding RNA and antisense transcripts. These genes may
discriminate cell types and prove instrumental in cell-specific
gene targeting. Clearly, there may be heterogeneity even within
the subsets we have analysed in the uterus and some of the genes
may be specific of smaller populations within the parent popu-
lation. Future work should capture the dynamic transcriptomic
changes within cell types and stages to reveal the biology of
uterine ILCs.
Methods
Mice. C57BL/6 (B6) WT mice were purchased from Charles River UK and Rag2
−/−Il2rg−/− mice maintained in house. Eomes-GFP reporter mice were a gift of
Thierry Walzer68, Rorc(γt)-CreTG/R26R mice from Gérard Eberl69 and Rosa26R-
EYFP from Ionel Sandovici. All strains were on B6 background. All animals were
used at 8–12 weeks of age and were age-matched for every experiment and all time-
matings. The morning of the copulation plug discovery was counted as the
gestation day (gd) 0.5 for time-matings. Mice were bred, maintained and mated
under pathogen-free conditions at the University of Cambridge Central Biomedical
Service in accordance with the University of Cambridge Animal Welfare and
Ethical Review Body and United Kingdom Home Office Regulations, as well as at
the Animal Facility of the IRCCS-AOU San Martino-IST in accordance with the
Italian and European Community guidelines.
Cell isolation and functional assays. Mouse uterus, liver and spleen were pro-
cessed using a protocol involving both mechanical and enzymatic processing.
Finely minced tissues were digested in Accutase (Invitrogen) for 35 min at 37°C
with gentle orbital agitation (80 rpm)70 or in Liberase DH (Roche) as described
previously14 for functional assays. Following digestion, tissues were passed through
the cell strainer (100 μm for uterus, 70 μm for liver and 40 μm for spleen) using a
plunger to mechanically dissociate remaining tissues. Leucocytes were then isolated
using 80%/40% Percoll gradient (GE Healthcare Life Sciences) and red blood cell
lysis was performed on the resulting cell pellet using BD Pharm Lyse buffer (BD
Biosciences) according to manufacturer’s instructions. Single cell suspensions
obtained in this way were used for downstream analysis and assays. For in vitro
stimulation, cells were incubated in a complete medium containing Cell Stimula-
tion Cocktail (plus protein transport inhibitors) during a 4-hour assay, alongside
Protein Transport Inhibitor Cocktail for control (both from Invitrogen).
Flow cytometry. Following biotin- or fluorochrome-conjugated antibodies specific
for the following antigens were used, with the dilutions in the brackets, after the
clone: CD45 (clone 30-F11, 100), CD3 (17A2, 50), CD19 (1D3, 100), CD11b (M1/
70, 100), NK1.1 (PK136, 100), NKp46 (29A1.4, 50), CD49a (Ha31/8, 300), Eomes
(Dan11mag, 100), CD86 (GL1, 50), F4/80 (BM8, 100), B220 (RA3-6B2, 100),
MerTK (REA477, 200), CXCR6 (SA051D1, 100), IL-22 (1H8PWSR, 100), NKG2D
(CX5), NKG2A/C/E (20d5, 100), CD69 (H1.2F3, 50), CD27 (LG.3A10, 50), CD62L
(MEL-14, 100), CD103 (2E7, 25), Ly49H (3D10, 100), Ly49G2 (4D11, 100), Ly49I
(YLI-90, 100), Ly49A (YE1/48.10.6, 50), Ly49D (4E5, 50), Ly49E/F (CM4, 100),
MHC-II (M5/114.15.2, 400), TruStain fcX (anti-mouse CD16/32, 100) for Fc-
receptor blocking and Fixable Viability Dye eFluor 506 (dilution: 1000) for live/
dead discrimination. All antibodies were purchased from Biolegend, Invitrogen
(eBioscience) or BD Biosciences. For intracellular and intranuclear staining, Foxp3/
Transcription Factor Staining Buffer Set (Invitrogen) was used according to
manufacturer’s instructions. Uterine and liver ILC1 were sorted from Eomes-GFP
reporter mice and analysed as live CD45+CD3−CD19−CD11blow/-NK1.1+NKp46
+CD49a+Eomes−, uterine trNK as live CD45+CD3−CD19−CD11blow/-NK1.1
+NKp46+CD49a+Eomes+ and uterine and liver cNK as live CD45+CD3−CD19
−CD11blow/-NK1.1+NKp46+CD49a−Eomes+. Samples were acquired on a LSR
Fortessa (BD Biosciences), sorted on FACSAria III instrument (BD Biosciences)
and analysed using FlowJo vX software (BD Biosciences).
RNA-sequencing and analysis. Group 1 ILCs from uterus and liver were sorted
from Eomes-GFP reporter mice into the TRI Reagent (Sigma). RNA extraction was
carried out by following TRI Reagent manufacturer’s instructions, followed by
RNeasy Micro kit (Qiagen). cDNA was amplified using Ovation RNA-seq system
V2 (NuGEN) and DNA libraries were produced using Ovation Ultralow System V2
(NuGEN) and following manufacturer’s instructions. All mRNA and cDNA quality
controls and quantifications were performed using RNA 6000 Pico and High
Sensitivity DNA kits (Agilent) on the 2100 Bioanalyzer instrument (Agilent). RNA
sequencing was performed on Illumina Hiseq4000 at the Cancer Research UK
Cambridge Institute Genomics Core. Data were aligned to GRCm38 mouse gen-
ome (Ensembl Release 84) with TopHat2 (v2.1.1, using bowtie2 v2.2.9) with a
double map strategy. Alignments and QC were processed using custom Cluster-
Flow (v0.5dev) pipelines and assessed using MultiQC (0.9.dev0). Gene quantifi-
cation was determined with HTSeq-Counts (v0.6.1p1). Additional quality control
was performed with feature counts (v 1.5.0-p2), qualimap (v2.2) and preseq
(v2.0.0). Differential gene expression was performed with DESeq2 package (v1.16.1,
R v3.4.2) and with the same package read counts were normalised on the estimated
size factors. Proportions of specific immune cell types from bulk RNA-Seq can be
estimated using reference data generated from known proportions of the cell types
of interest71. DeconRNASeq72 was applied to take these tables of known cell
proportions, defined by gene expression profiles, and used to deconvolute bulk
dataset generated in this study to estimate cell proportions within each of the
sequence’s samples. Gene Ontology (biological process) analysis was performed
using PANTHER (Protein ANalysis THrough Evolutionary Relationships database
http://www.pantherdb.org). Lists of differentially expressed genes (adjusted p < 0.05
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and log2 fold change two or above) were submitted to PANTHER Over-
representation Test (released 2017-12-05), with Fisher’s exact testing utilising a
false discovery rate multiple test correction and a Mus Musculus reference list.
Further details on annotation versions and release dates can be found in the
Supplementary Data 1.
RT-qPCR. Whole uterus was isolated at time-points of interest, collected in
RNAlater (Invitrogen) to stabilise the RNA and kept at 4 °C overnight. Tissue was
homogenised in the Lysing Matrix S homogenisation tubes (MP Biomedicals) on a
FastPrep-24 5G Homogenizer (MP Biomedicals) using RNeasy Plus Universal Kit
(Qiagen) according to manufacturer’s instruction. Isolated RNA quality control
and quantification was performed using RNA 6000 Nano kit (Agilent) on the 2100
Bioanalyzer instrument (Agilent). cDNA was amplified using SuperScript VILO
cDNA Synthesis kit (Invitrogen) and qPCR was performed using PowerUP SYBR
Green Master Mix (Applied Biosystems), on the Quant Studio 6 Flex Real-Time
PCR System (Thermo Fisher – Applied Biosystems). Gapdh was used as a reference
gene. Data were analysed using the ΔΔCt method. Primers were as follows: Spp1,
5′-TTCACTCCAATCGTCCCTAC-3′ (forward) and 5′-TTAGACTCACCGCTCT
TCAT-3′ (reverse); Ogn, 5′-TGCTTTGTGGTCACATGGAT-3′ (forward) and 5′-
GAAGCTGCACACAGCACAAT-3′ (reverse); Ptn, 5′-TGGAGAATGGCAGTGG
AGTGT-3′ (forward) and 5′-GGCGGTATTGAGGTCACATTC-3′ (reverse) and
Gapdh, 5′-TGCACCACCAACTGCTTAG-3′ (forward) and 5′-GGATGCAGGGA
TGATGTTC-3′ (reverse). Ccl2, Ccl7 and Ccl12 were assayed using Thermo Fisher
TaqMan (Assays IDs Mm00441242_m1, Mm00443113_m1, Mm01617100_m1)
with Gapdh as a reference gene (Assay ID Mm99999915_g1).
Statistical analysis and figure preparation. Statistical parameters and tests
applied are reported in the figure legends. All statistical analyses were performed in
Prism 7 (GraphPad Software) with a confidence level of 0.95. p-values above 0.05
were considered insignificant and are not indicated in the figures. Figures were
prepared using BioRender and Illustrator CC 2018 (Adobe).
Data availability
All relevant data are available from the corresponding author upon reasonable
request. RNA-sequencing data have been deposited in ArrayExpress database at
EMBL-EBI under accession number E-MTAB-6812 (https://www.ebi.ac.uk/
arrayexpress/experiments/E-MTAB-6812). An open-source repository (https://
github.com/CTR-BFX/2018-Filipovic-Colucci) has been created with access to the
code used in this study.
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